These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22820525)

  • 1. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
    Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as nano-theranostic delivery platforms for gene therapy.
    Tan A; Rajadas J; Seifalian AM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):357-67. PubMed ID: 22820532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes: Natural Carriers for siRNA Delivery.
    Kumar L; Verma S; Vaidya B; Gupta V
    Curr Pharm Des; 2015; 21(31):4556-65. PubMed ID: 26486142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo delivery aspects of miRNA, shRNA and siRNA.
    Khatri N; Rathi M; Baradia D; Trehan S; Misra A
    Crit Rev Ther Drug Carrier Syst; 2012; 29(6):487-527. PubMed ID: 23176057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.
    Wahlgren J; De L Karlson T; Brisslert M; Vaziri Sani F; Telemo E; Sunnerhagen P; Valadi H
    Nucleic Acids Res; 2012 Sep; 40(17):e130. PubMed ID: 22618874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
    Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
    Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.
    Alvarez-Erviti L; Seow Y; Yin H; Betts C; Lakhal S; Wood MJ
    Nat Biotechnol; 2011 Apr; 29(4):341-5. PubMed ID: 21423189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes: natural nanoparticles as bio shuttles for RNAi delivery.
    Darband SG; Mirza-Aghazadeh-Attari M; Kaviani M; Mihanfar A; Sadighparvar S; Yousefi B; Majidinia M
    J Control Release; 2018 Nov; 289():158-170. PubMed ID: 30290245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion.
    Pegtel DM; van de Garde MD; Middeldorp JM
    Biochim Biophys Acta; 2011; 1809(11-12):715-21. PubMed ID: 21855666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles for short interfering RNA delivery.
    Leung AK; Tam YY; Cullis PR
    Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-mediated delivery of siRNA in vitro and in vivo.
    El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJ
    Nat Protoc; 2012 Dec; 7(12):2112-26. PubMed ID: 23154783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive review on the composition, biogenesis, purification, and multifunctional role of exosome as delivery vehicles for cancer therapy.
    Li J; Zhang Y; Dong PY; Yang GM; Gurunathan S
    Biomed Pharmacother; 2023 Sep; 165():115087. PubMed ID: 37392659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes: Nanoparticulate tools for RNA interference and drug delivery.
    Shahabipour F; Barati N; Johnston TP; Derosa G; Maffioli P; Sahebkar A
    J Cell Physiol; 2017 Jul; 232(7):1660-1668. PubMed ID: 28063231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.